⌘K

Login Start Free

Home/Filings/4/0001140361-19-010673

4//SEC Filing

Sullivan Lara 4

Accession 0001140361-19-010673

CIK 0001228627other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:17 PM ET

Size

4.9 KB

Accession

0001140361-19-010673

Insider Transaction Report

Form 4

Period: 2019-06-06

REXAHN PHARMACEUTICALS, INC.RNN

Director

Transactions

Award
Stock Option (right to buy)
2019-06-06+3,537→ 3,537 total
Exercise: $5.23From: 2020-06-06Exp: 2029-06-06→ Common Stock (3,537 underlying)

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeother

Related Parties

1

filerCIK 0001769457

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 4:17 PM ET
Size: 4.9 KB

View on SEC.gov